Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Double-dummy, Multi-center Study to Investigate the Safety and Efficacy of Olmesartan Medoxomil Compared With Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

NCT00856271 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00856271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Double-dummy, Multi-center Study to Investigate the Safety and Efficacy of Olmesartan Medoxomil Compared With Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
April 30, 2005
Enrollment
287 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension